I don’t think de-extinction of animals just for the heck of it like woolly mammoths is a good idea, but what about de-extincting animals like the Dodo? Where humans caused them to disappear? If that’s even possible, is it a good idea? Dodo de-extinction A company is giving it a try. I can see the …
Weekly reads: De-extinction pros & cons with Dodo 2.0, CTCF, retraction Read More »
The push for de-extinction of woolly mammoths is a perfect example of when one notion can be both fun and a rotten idea. You can’t let the coolness push you down a bad path. You can see my new YouTube video covering the main points of this post from our YouTube channel further down. Please …
Why De-extinction of Woolly Mammoths is Still a Bad Idea Read More »
This is wild! George Church is amazing. And a screenshot below. Wow.
De-extinction is big right now and some of the extinct target creatures are big too like the woolly mammoth. “Let’s bring back these extinct creatures”, say proponents. Wouldn’t it be cool? I have to admit seeing a woolly mammoth, mastodon, or saber tooth tiger would be cool, but such efforts would not be without consequences …
Toward the end of each year, I make stem cell & regenerative medicine predictions for the coming year. It’s a fun tradition here on The Niche that goes way back. The stem cell field has changed dramatically as reflected in each year’s predictions. Here’s a list of past predictions with my grades of how they …
2023 stem cell & regenerative medicine predictions Read More »
I’ve tried to find some time to do some stem cell and other regenerative medicine reading too, but it’s been a busy week of teaching for me as a professor in our new academic year for the UC Davis School of Medicine. I help to teach the Histology part of the first-year curriculum. It’s an …
Regenerative medicine reads: retraction, FDA warning, CAR-T, ARM CEO Read More »
The last six months I’ve been spending even more time than usual writing NIH grants (and a few others). The last two weeks have been especially busy on this front as I am getting an R01 renewal out the door. My paper reading lately has been mostly related to the grant writing I’m doing. Still, …
Weekly reads: NIH grants, side effect of darker hair, FDA warning, CRISPR Read More »
The big news of the week was a $3.6 million settlement by a stem cell clinic, StemGenex, and one of its doctors in a class-action suit. I covered this StemGenex settlement and so did Michael Hiltzik of the LA Times and Paul Schloesser at Endpoints. I’d say this was good news for the stem cell field …
Stem cell weekly reads: Jamie Thomson, Lamin B1, CRISPR Read More »
I’ve been busy recently focusing more on grant and paper writing than reading papers on stem cells, but my piece on trying to de-extinct mammoths via cloning-like methods drew strong opinions on both sides. Recent news and resources on stem cells We’re still awaiting a verdict in the big California federal court case where the FDA is …
Weekly reads: news, legos for stem cells, FDA, cancer, more Read More »
The title of a new article in Stem Cells and Development may seem audacious to those unfamiliar with the plight of the northern white rhino and the promise of induced pluripotent stem cells. But “Rewinding Extinction in the Northern White Rhinoceros” may turn out to be accurate for what a genetically diverse stem cell bank …